In uPA-treated MCF-7 breast carcinoma cells, uPAR/αvß5 association directs cytoskeletal rearrangements and cell migration through PKC activity, whereas binding of Vn to αvß5 results in distinct, PKC-independent effects (Carriero et al., 1999). This evidence concerns the gene PRRT2 and breast carcinoma.